IMM 1.18% 43.0¢ immutep limited

An obsevation re Eftiligomab alfa

  1. 25,265 Posts.
    lightbulb Created with Sketch. 1364
    We are getting near the pointy end of research into Efti's effectiveness in assisting treatment for various cancer indications....
    In combination with keytruda it is showing better results with more successful outcomes for patients than keytruda alone
    in trials conducted sofar....Even signs of a combo that can negate the need for chemotherapy in certrain cases....
    To be brutally honest, there is gonna need to be a major reversal in trial data over the next few months for Efti to fall over...
    We have much to look forward to here and to be honest once again there is cause for confidence...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
43.0¢
Change
0.005(1.18%)
Mkt cap ! $511.1M
Open High Low Value Volume
42.5¢ 43.0¢ 41.5¢ $2.818M 6.626M

Buyers (Bids)

No. Vol. Price($)
6 168332 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 129388 6
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
43.0¢
  Change
0.005 ( 0.51 %)
Open High Low Volume
42.5¢ 43.0¢ 41.5¢ 818937
Last updated 15.59pm 07/06/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.